Christopher Rovaldi's most recent trade in Keros Therapeutics Inc was a trade of 60,000 Common Stock done . Disclosure was reported to the exchange on Feb. 18, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Keros Therapeutics Inc | Christopher Rovaldi | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 60,000 | 60,000 | - | 0 | Common Stock | |
| Keros Therapeutics Inc | Christopher Rovaldi | CHIEF OPERATING OFFICER | 13 Feb 2024 | 150,000 | 150,000 | - | - | Employee Stock Option (right to buy) | ||
| Keros Therapeutics Inc | Christopher Rovaldi | Chief Operating Officer | 16 Feb 2023 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) | ||
| Keros Therapeutics Inc | Christopher Rovaldi | Chief Operating Officer | 06 Apr 2022 | 1,728 | 0 | - | 65 | 112,320 | Common Stock | |
| Keros Therapeutics Inc | Christopher Rovaldi | Chief Operating Officer | 06 Apr 2022 | 1,728 | 8,002 | - | - | Employee Stock Option (right to buy) | ||
| Keros Therapeutics Inc | Christopher Rovaldi | Chief Operating Officer | 06 Apr 2022 | 1,728 | 1,728 | - | 16 | 27,648 | Common Stock | |
| Keros Therapeutics Inc | Christopher Rovaldi | Chief Operating Officer | 01 Apr 2022 | 864 | 864 | - | 16 | 13,824 | Common Stock | |
| Keros Therapeutics Inc | Christopher Rovaldi | Chief Operating Officer | 01 Apr 2022 | 864 | 9,730 | - | - | Employee Stock Option (right to buy) | ||
| Keros Therapeutics Inc | Christopher Rovaldi | Chief Operating Officer | 01 Apr 2022 | 366 | 105 | - | 58.0 | 21,217 | Common Stock | |
| Keros Therapeutics Inc | Christopher Rovaldi | Chief Operating Officer | 01 Apr 2022 | 287 | 471 | - | 56.9 | 16,327 | Common Stock | |
| Keros Therapeutics Inc | Christopher Rovaldi | Chief Operating Officer | 01 Apr 2022 | 105 | 0 | - | 58.8 | 6,177 | Common Stock | |
| Keros Therapeutics Inc | Christopher Rovaldi | Chief Operating Officer | 01 Apr 2022 | 104 | 758 | - | 56.2 | 5,845 | Common Stock | |
| Keros Therapeutics Inc | Christopher Rovaldi | Chief Operating Officer | 01 Apr 2022 | 2 | 862 | - | 54.5 | 109 | Common Stock | |
| Keros Therapeutics Inc | Christopher Rovaldi | Chief Operating Officer | 01 Feb 2022 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) |